Klöckner Pentaplast’s pharma and medical device division (kp PMD) announced that it will expand its global production capacity in North America.
kp PMD president Tracey Peacock said: “Our significant expansion plans reflect our dedication to servicing customers’ needs now, and in the future.
“The additional coating and laminating capability suitable for the production of Pentapharm and Pentamed packaging films will service the North American pharmaceutical and medical device industry.
“We are excited to support the growing high barrier product segments by investing in best in class coating and laminating capabilities, enabling new performance levels in barrier protection.”
kp PMD is investing $25m over the next few years in technology and processes to ensure they deliver innovative, functional and safe products for customers.
This investment in North America complements earlier announcements by kp this year, highlighting their capacity expansions in Switzerland and Brazil. kp plans for the new capability in North America to be operational in 2020.
Visit the team at Healthcare Packaging Expo (part of PackExpo), booth #864 from 14-17th October 2018 in Chicago, Illinois to learn more about kp PMD and their products.
The Klöckner Pentaplast Group is a global leader in rigid and flexible packaging, printing and specialty solutions, serving the pharmaceutical, medical device, food, beverage and card markets, amongst others.
With a broad portfolio of packaging, films and services, Klöckner Pentaplast plays an integral role in its customers’ value chains, safeguarding product integrity, assuring safety and consumer health, improving sustainability and protecting brand reputation.
Founded in 1965, Klöckner Pentaplast has operations in 18 countries and employs over 6,300 people committed to serving customers worldwide from 61 locations, including 32 production sites.
Source: Company Press Release